Capital International Investors’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.66B | Sell |
3,165,263
-823,869
| -21% | -$433M | 0.29% | 83 |
|
|
2025
Q1 | $2.53B | Sell |
3,989,132
-747,797
| -16% | -$474M | 0.5% | 50 |
|
|
2024
Q4 | $3.37B | Buy |
4,736,929
+1,390,534
| +42% | +$990M | 0.63% | 39 |
|
|
2024
Q3 | $3.52B | Buy |
3,346,395
+212,273
| +7% | +$223M | 0.68% | 37 |
|
|
2024
Q2 | $3.29B | Buy |
3,134,122
+5,112
| +0.2% | +$5.37M | 0.68% | 40 |
|
|
2024
Q1 | $3.01B | Buy |
3,129,010
+213,038
| +7% | +$205M | 0.61% | 45 |
|
|
2023
Q4 | $2.56B | Sell |
2,915,972
-58,366
| -2% | -$51.3M | 0.57% | 47 |
|
|
2023
Q3 | $2.45B | Buy |
2,974,338
+17,723
| +0.6% | +$14.6M | 0.62% | 42 |
|
|
2023
Q2 | $2.12B | Buy |
2,956,615
+803,143
| +37% | +$577M | 0.51% | 53 |
|
|
2023
Q1 | $1.77B | Buy |
2,153,472
+623,529
| +41% | +$512M | 0.46% | 67 |
|
|
2022
Q4 | $1.1B | Sell |
1,529,943
-237,193
| -13% | -$171M | 0.3% | 92 |
|
|
2022
Q3 | $1.22B | Sell |
1,767,136
-24,799
| -1% | -$17.1M | 0.36% | 77 |
|
|
2022
Q2 | $1.06B | Buy |
1,791,935
+108,036
| +6% | +$63.9M | 0.29% | 96 |
|
|
2022
Q1 | $1.18B | Buy |
1,683,899
+1,417,899
| +533% | +$990M | 0.27% | 102 |
|
|
2021
Q4 | $168M | Sell |
266,000
-865,968
| -77% | -$547M | 0.04% | 282 |
|
|
2021
Q3 | $685M | Sell |
1,131,968
-158,178
| -12% | -$95.7M | 0.16% | 139 |
|
|
2021
Q2 | $721M | Sell |
1,290,146
-15
| -0% | -$8.38K | 0.16% | 134 |
|
|
2021
Q1 | $610M | Sell |
1,290,161
-74,665
| -5% | -$35.3M | 0.15% | 142 |
|
|
2020
Q4 | $659M | Sell |
1,364,826
-78,158
| -5% | -$37.8M | 0.18% | 129 |
|
|
2020
Q3 | $808M | Sell |
1,442,984
-127,490
| -8% | -$71.4M | 0.25% | 102 |
|
|
2020
Q2 | $979M | Sell |
1,570,474
-51,741
| -3% | -$32.3M | 0.32% | 81 |
|
|
2020
Q1 | $792M | Buy |
1,622,215
+104,782
| +7% | +$51.2M | 0.32% | 80 |
|
|
2019
Q4 | $570M | Buy |
1,517,433
+503
| +0% | +$189K | 0.19% | 126 |
|
|
2019
Q3 | $421M | Buy |
1,516,930
+21
| +0% | +$5.83K | 0.16% | 138 |
|
|
2019
Q2 | $475M | Sell |
1,516,909
-62,205
| -4% | -$19.5M | 0.19% | 125 |
|
|
2019
Q1 | $648M | Buy |
1,579,114
+50,002
| +3% | +$20.5M | 0.28% | 98 |
|
|
2018
Q4 | $571M | Sell |
1,529,112
-211,000
| -12% | -$78.8M | 0.28% | 92 |
|
|
2018
Q3 | $703M | Buy |
+1,740,112
| New | +$703M | 0.32% | 84 |
|
|
2016
Q4 | – | Sell |
-93,810
| Closed | -$37.7M | – | 249 |
|
|
2016
Q3 | $37.7M | Buy |
93,810
+368
| +0.4% | +$148K | 0.05% | 211 |
|
|
2016
Q2 | $32.6M | Buy |
93,442
+109
| +0.1% | +$38.1K | 0.05% | 215 |
|
|
2016
Q1 | $33.6M | Buy |
93,333
+44
| +0% | +$15.9K | 0.05% | 214 |
|
|
2015
Q4 | $50.6M | Buy |
+93,289
| New | +$50.6M | 0.08% | 198 |
|
|
2015
Q3 | – | Sell |
-36
| Closed | -$18K | – | 269 |
|
|
2015
Q2 | $18K | Buy |
+36
| New | +$18K | ﹤0.01% | 256 |
|